IMM 1.56% 31.5¢ immutep limited

top up opportunity - technical counsel. , page-4

  1. 339 Posts.
    lightbulb Created with Sketch. 25
    Just read DNDN news. As I understand it, that aint good news for PRR. Perhaps people aren't willing to ante up for simply prolonging life by a few months. Sounds like the production stage is quite complex and expensive for these treatments, and it's a tradeoff for insurance companies. Hmmm. Based on the strong volume, it looks like some smart money is playing today. Beware guys.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.